Cargando…
Do COVID-19 viral infection and its mRNA vaccine carry an equivalent risk of myocarditis? Review of the current evidence, insights, and future directions
According to recent epidemiological analysis, the percentage of world population infected with COVID-19 by end of December 2020 is approximately 12.56%(1). COVID induced acute care and ICU hospitalization rates are around 9.22 (95% CI: 18.73–19.51), and 4.14 (95% CI: 4.10–4.18) per 1000 population(1...
Autores principales: | Ulucay, Ayse Sena, Singh, Gaaminepreet, Kanuri, Sri Harsha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10421995/ https://www.ncbi.nlm.nih.gov/pubmed/37399904 http://dx.doi.org/10.1016/j.ihj.2023.06.009 |
Ejemplares similares
-
COVID-19 HEART unveiling as atrial fibrillation: pathophysiology, management and future directions for research
por: Kanuri, Sri Harsha, et al.
Publicado: (2023) -
Prognosis of Myocarditis Developing After mRNA COVID-19 Vaccination Compared With Viral Myocarditis
por: Lai, Francisco Tsz Tsun, et al.
Publicado: (2022) -
Pharmacogenomics of Novel Direct Oral Anticoagulants: Newly Identified Genes and Genetic Variants
por: Kanuri, Sri H., et al.
Publicado: (2019) -
Myocarditis and inflammatory cardiomyopathy: current evidence and future directions
por: Tschöpe, Carsten, et al.
Publicado: (2020) -
HIGHLIGHTING THE RISE OF VACCINE-ASSOCIATED MYOCARDITIS AND WHAT IT MEANS FOR THE FUTURE OF MRNA VACCINES
por: Anthony, Jamal A., et al.
Publicado: (2022)